NCT05653700

Arena Labs - Improving Clinician Well Being

Atrium Health - Arena Labs Research Protocol

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Wake Forest University Health Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To determine the efficacy of the asynchronous performance coaching platform, Arena Strive at changing measures of physiological resilience, professional fulfillment, burnout, and self-valuation in full time clinicians.

Detailed description

This study is a prospective randomized controlled longitudinal crossover design with a per protocol analysis integrating one sensor (WHOOP, inc Platform) and one educational intervention (Arena Strive Platform). The WHOOP sensor collects data on heart rate (HR), heart rate variability (HRV), and sleep data, and will be worn by all participants in the experimental intervention. Participants will be asked to wear the biometric sensor for 12 weeks but will have optional access to the device for a total of 24 weeks.

Conditions

• Mental Health Disorder

Interventions

Type	Name	Description
DEVICE	Arena Strive	This second-generation platform provides frontline clinicians with a comprehensive journey to access the tools, training, and technology used by other high-pressure fields to increase performance and enhance resilience. The experimental intervention employed in this study will be a 12-week, multi-phased approach involving an asynchronous learning and coaching experience (6 weeks), and exploration phase (6 weeks).
OTHER	Control Cohort	Participants randomized into the control cohort - survey at baseline and end of the study

Timeline

• Start date: 2023-03-16
• Primary completion: 2023-07-25
• Completion: 2023-07-25
• First posted: 2022-12-16
• Last updated: 2024-12-04
• Results posted: 2024-12-04

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study